Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Systemic lupus erythematous (SLE) is known to be associated with cardiovascular events (CVEs). However, the incidence of CVE has not been thoroughly investigated in lupus nephritis (LN) patients. In this meta-analysis, we aimed to assess the incidence of CVE in patients with LN.
Methods: We performed a literature search in PubMed, Scopus, and Web of Science database for studies reporting CVE (myocardial infarction [MI], heart failure, cerebrovascular accident [CVA] [i.e., ischemic or hemorrhagic stroke or transient ischemic attack], any cardiovascular- or cerebrovascular-related disease or death) in patients with LN. In addition, subgroup analyses were conducted according to geographical locations and kidney disease status. We also separately reported the incidence rate of MI, CVA, and cardiovascular- or cerebrovascular-related deaths, with CVE and MI risk in patients with LN.
Results: Twenty-one records, encompassing 29,489 subjects, were included. The overall CVE incidence was 9% (95% confidence interval [CI]: 6-12%). Specifically, the incidence of MI (8 studies, = 5,735), CVA (9 studies, = 6,053), and mortality attributed to any cardiovascular or cerebrovascular disease (10 studies, = 26,511) were 4% (95% CI: 2-7%), 4% (95% CI: 2-7%), and 5% (95% CI: 3-7%), respectively. Geographically, patients residing in Asia exhibited a lower incidence of CVE (2.3%, 95% CI: 1.6-3.3%) compared to those residing in North America (10.1%, 95% CI: 5.7-17.2%) and Europe (13.3%, 95% CI: 7.6-22.4%). Patients with LN had higher risk of CVE compared to SLE subjects (odds ratio: 1.18, 95% CI: 1.03-1.34, = 0.014).
Conclusion: CVE occurrence among individuals with LN is significant, and this disease entity increases CVE risk, highlighting the importance of implementing early therapeutic interventions to prevent poor outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12178181 | PMC |
| http://dx.doi.org/10.1159/000546177 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy and safety of different proprotein convertase subtilisin/kexin type 9 inhibitors in the general population and solid organ transplant recipients: a network meta-analysis.
Front Pharmacol
August 2025
Department of Hepatobiliary Surgery, Zigong Fourth People's Hospital, Zigong, China.
Introduction: We conducted a network meta-analysis (NMA) to compare the efficacy (primarily assessed by low-density lipoprotein cholesterol (LDL-C) reduction and cardiovascular event (CVE) incidence) and safety (total adverse events (AEs), neurocognitive events (NCEs), injection site reactions, infections, and all-cause mortality (ACM)) of different Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors placebo in the general population and solid organ transplant (SOT) recipients.
Materials And Methods: A total of 16 randomized controlled trials (RCTs) involving 79,615 patients were included. Cochrane risk of bias assessment tool evaluated the literature quality.
Primary Aldosteronism and Long-Term Cardiovascular Complications: Comparison of Medical Versus Surgical Treatment.
J Clin Hypertens (Greenwich)
August 2025
Vascular Medicine and Arterial Hypertension Department, La Timone Hospital, Marseille, France.
The study aims to evaluate the long-term incidence of cardiovascular events (CVE) and compare the effectiveness of medical and surgical interventions using a combined cardiovascular endpoint in individuals diagnosed with primary aldosteronism (PA). The authors carried out a multicentric, retrospective study in Marseille on a total of 106 inpatients divided into two samples with biologically proven primary aldosteronism, of whom 55 underwent surgical treatment and 51 received medical therapy between January 2014 and December 2022. The mean age of the sample was 53 years.
View Article and Find Full Text PDFPotential role of the spleen in the development of arterial hypertension in humans.
J Hypertens
August 2025
Division of Internal Medicine, Department of Clinical and Experimental Sciences, ASST Spedali Civili Brescia, University of Brescia.
Objectives: Immunity, particularly T lymphocytes, plays an important role in the development of arterial hypertension. Moreover, the so-called neuro-immune axis has been identified as a crucial crossroads, occurring in the spleen and involving placental growth factor as the principal mediator. However, no studies in humans have yet investigated the role of the spleen in hypertension and vascular damage.
View Article and Find Full Text PDFAim To assess the effect of annual seasonal flu vaccination for 3 years on the risk of acute respiratory infection (ARI) and cardiovascular events (CVE) in cardiological patients followed up using two analytical methods.Material and methods This prospective comparative study included 817 patients in October 2012. CVE, other chronic non-communicable diseases, and ARI recorded from October 2012 through November 2015 were analyzed.
View Article and Find Full Text PDFNeck circumference predicts the incident cardiac events of obese hypertension with obstructive sleep apnea.
Am J Prev Cardiol
September 2025
Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Urumuqi, PR China.
Background: Elevated NC has been indicated as a risk factor for hypertensive with obstructive sleep apnea (OSA) in our previous cross-sectional study, but limited data are available regarding the prognostic value of elevated NC and cardiovascular outcome(CVD) in Chinese hypertensives with OSA.
Methods: This study included hospitalized hypertensive patients with recorded NC measurements at baseline (2011-2013) by using the data from a large retrospective cohort study (UROSAH Study). Baseline characteristics of the included participants were summarized by the median of NC.